GCTK Glucotrack, Inc.

$0.37 -3.16%

Healthcare · Surgical & Medical Instruments & Apparatus

Glucotrack, Inc. (GCTK) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $2 million. Shares last traded at $0.37, 97.6% below their 52-week high. Over the past year the stock is up 136.1%. Net profit margin is -9321.2%, below the peer median of -7.6%. Revenue grew 378.3% year over year.

Market Cap

$2M

Shares Out

6.3M

EPS (TTM)

$107.69

P/E Ratio

0.00

P/S Ratio

11.27

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$15.86

52-Week Low

$0.09

Volume

1,562

Avg Vol (3m)

94,891.603

Performance

-6.96%

-31.62%

-65.01%

-93.35%

YTD

-90.55%

+136.07%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

29.27

SMA (50)

$0.65

SMA (200)

$3.33

Price vs SMA50

-42.41%

Price vs SMA200

-88.77%

ATR (14)

$0.09

Financials

Revenue

$0M

Net Income

$-19M

Gross Margin

—

Operating Margin

-7735.6%

Net Margin

-9321.2%

Return on Equity

2278.3%

Return on Assets

-445.1%

Current Ratio

0.85

Debt / Equity

-6.12

Revenue Growth (YoY)

+378.3%

Latest reported annual period ending 2019-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$2.65	2026-05-14
FY 2025	$31.22	2026-03-30
Q3 2025	$30.09	2025-11-13
Q2 2025	$34.81	2025-08-14
Q1 2026	$40.14	2026-05-14
FY 2025	$4106.00	2026-03-30

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

GCTK vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

11.27 / 2.52 med

+347% premium

Net margin vs peers

-9321.2% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.